Biomarkers and ImmuneScores in lung cancer: predictive insights for immunotherapy and combination treatment strategies
Abstract Lung cancer remains the leading cause of cancer related deaths worldwide. Immunotherapy and combination therapies, involving chemotherapy, radiotherapy, and tumor anti-angiogenesis therapy, have shown promising clinical results and are expected to become a key approach in the future managem...
Saved in:
| Main Authors: | Xiaoyu Yang, Bin Luo, Jianhui Tian, Yanhong Wang, Xinyi Lu, Jian Ni, Yun Yang, Lei Jiang, Shengxiang Ren |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Biological Procedures Online |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12575-025-00287-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamic Alteration of HALP Score as a Predictor in Patients with Receiving Immunotherapy for Advanced Non-Small Cell Lung Cancer
by: Abdülkadir Koçanoğlu, et al.
Published: (2025-05-01) -
Advances in biomarkers for immunotherapy in small-cell lung cancer
by: Hui Li, et al.
Published: (2024-12-01) -
Biomarkers for immunotherapy resistance in non-small cell lung cancer
by: Catriona Rother, et al.
Published: (2024-12-01) -
Recent advances and challenges of cellular immunotherapies in lung cancer treatment
by: Chengfei Yang, et al.
Published: (2025-07-01) -
Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities
by: Huiyu Wang, et al.
Published: (2025-08-01)